FDA action counts
| Total FDA actions | 1 |
|---|---|
| Warning letters | 0 |
| Recalls | 0 |
| Approval records | 1 |
| Form 483 inspection citations | 0 |
| Most recent action | September 25, 2026 |
Risk pattern analysis
Argus HQ analysis — not an FDA finding
This section is Argus HQ analysis, not an FDA finding. AZURITY PHARMACEUTICALS INC has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Enforcement history
On 2026-09-25, Argus HQ recorded an FDA approval for AZURITY PHARMACEUTICALS INC, rated "info" severity in Argus HQ's classification: AZURITY PHARMACEUTICALS INC — NDA approval: Unspecified (unspecified). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.
Frequently asked questions
- How many FDA actions does Argus HQ track for AZURITY PHARMACEUTICALS INC?
- 1 total: 0 warning letters, 0 recalls, 1 approval record, and 0 Form 483 inspection citations.
- What is the most recent FDA action on file for AZURITY PHARMACEUTICALS INC?
- September 25, 2026. Argus HQ ingests new FDA enforcement records daily.
- Is this FDA enforcement data for AZURITY PHARMACEUTICALS INC official?
- Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.
- How many FDA actions has AZURITY PHARMACEUTICALS INC had?
- Argus HQ has recorded 1 FDA events for AZURITY PHARMACEUTICALS INC: 0 warning letters, 0 recalls, 1 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Every FDA action tied to this company, the week it happens.
Free weekly briefing. Real-time alerts on paid plans.
Related enforcement actions
Compare with
Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Verified from FDA.gov · Last updated: Sep 25, 2026Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). Regulatory Record: AZURITY PHARMACEUTICALS INC. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/company/azurity-pharmaceuticals-inc
"Regulatory Record: AZURITY PHARMACEUTICALS INC." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/company/azurity-pharmaceuticals-inc.
Argus HQ Research. "Regulatory Record: AZURITY PHARMACEUTICALS INC." Digital Empire Holdings LLC. Accessed October 3, 2026. https://argushq.ai/company/azurity-pharmaceuticals-inc.
@misc{argushq_argushq_ai_company_azurity_pharmaceuticals_inc_2026,
title = {Regulatory Record: AZURITY PHARMACEUTICALS INC},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/company/azurity-pharmaceuticals-inc},
note = {Accessed: October 3, 2026}
}Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗